Literature DB >> 16318956

Enhanced prolactin levels in opium smokers.

Ghollam-Reza Moshtaghi-Kashanian1, Farzaneh Esmaeeli, Shahriar Dabiri.   

Abstract

In Iran, opium is smoked for pleasure or as a medication by some people. It is a complex mixture of 40 different alkaloids, including morphine and codeine along with many impurities. Although it is well established that opioids or tobacco affect many physiological functions in humans, to our knowledge there has been no specific study looking at these effects in opium smokers. To assess that, we investigated the circulating levels of prolactin, TSH, LH, FSH and testosterone in male opium smokers who also smoke cigarettes (n=23, aged 28.4+/- 4.1 years), and comparing this with the corresponding values for nicotine abusers (n=12, 15-25 cigarettes/day) or a healthy control group (n=20) of the same age. Our results showed that 86.96% of the opium-dependent and 41.67 % of the nicotine-dependent group displayed high prolactin values (p<0.002). In addition, there was a positive correlation between the dose of opium and the plasma prolactin level of opium dependents (p=0.748, p<0.001). Low FSH was detected in 43.48% of the opium smokers and 50% of the cigarette smokers (p<0.001) with normal LH and testosterone levels. TSH of the opium smokers was also lower than that of the other two groups (p<0.002). In conclusion, the present data indicate that chronic opium and cigarette smoking may synergistically influence pituitary hormone production through the effects on neuropeptides produced either locally or systemic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16318956     DOI: 10.1080/13556210500351263

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  13 in total

Review 1.  Effects of opium consumption on cardiometabolic diseases.

Authors:  Farzad Masoudkabir; Nizal Sarrafzadegan; Mark J Eisenberg
Journal:  Nat Rev Cardiol       Date:  2013-10-22       Impact factor: 32.419

2.  Opioid analgesics suppress male gonadal function but opioid use in males and females does not correlate with symptoms of sexual dysfunction.

Authors:  Dana Wong; Dan P Gray; Mark Simmonds; Saifee Rashiq; Igor Sobolev; Donald W Morrish
Journal:  Pain Res Manag       Date:  2011 Sep-Oct       Impact factor: 3.037

3.  Prevalence of dyslipidemia and its association with opium consumption in the Rafsanjan cohort study.

Authors:  Zahra Jamali; Mojgan Noroozi Karimabad; Parvin Khalili; Tabandeh Sadeghi; Ahmadreza Sayadi; Faegheh Mohammadakbari Rostamabadi; Carlo La Vecchia; Ali Esmaeili-Nadimi
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

Review 4.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

5.  Biphasic effects of moderate drinking on prolactin during lactation.

Authors:  Julie A Mennella; Marta Yanina Pepino
Journal:  Alcohol Clin Exp Res       Date:  2008-08-18       Impact factor: 3.455

Review 6.  What can we learn from rodents about prolactin in humans?

Authors:  Nira Ben-Jonathan; Christopher R LaPensee; Elizabeth W LaPensee
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

7.  THE EFFECTS OF OPIUM ADDICTION ON THYROID AND SEX HORMONES IN DIABETIC AND NON-DIABETIC MALE AND FEMALE RATS.

Authors:  G Asadikaram; H Akbari; S Vakili; M Asiabanha; N Shahrokhi; A Savardashtaki
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Oct-Dec       Impact factor: 0.877

8.  Is opium addiction a risk factor for bone loss?

Authors:  M H Gozashti; A Shahesmaeili; N Amini Zadeh
Journal:  Iran Red Crescent Med J       Date:  2011-07-01       Impact factor: 0.611

9.  Hormonal and dietary characteristics in obese human subjects with and without food addiction.

Authors:  Pardis Pedram; Guang Sun
Journal:  Nutrients       Date:  2014-12-31       Impact factor: 5.717

10.  Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and route of administration matter?

Authors:  Sedigheh Asgary; Nizal Sarrafzadegan; Gholam-Ali Naderi; Reza Rozbehani
Journal:  Lipids Health Dis       Date:  2008-11-03       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.